1. Home
  2. LSTA vs MXE Comparison

LSTA vs MXE Comparison

Compare LSTA & MXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • MXE
  • Stock Information
  • Founded
  • LSTA 1980
  • MXE 1990
  • Country
  • LSTA United States
  • MXE United States
  • Employees
  • LSTA N/A
  • MXE N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • MXE Finance Companies
  • Sector
  • LSTA Health Care
  • MXE Finance
  • Exchange
  • LSTA Nasdaq
  • MXE Nasdaq
  • Market Cap
  • LSTA 22.5M
  • MXE 47.5M
  • IPO Year
  • LSTA N/A
  • MXE N/A
  • Fundamental
  • Price
  • LSTA $2.70
  • MXE $10.54
  • Analyst Decision
  • LSTA Strong Buy
  • MXE
  • Analyst Count
  • LSTA 2
  • MXE 0
  • Target Price
  • LSTA $23.50
  • MXE N/A
  • AVG Volume (30 Days)
  • LSTA 26.6K
  • MXE 5.8K
  • Earning Date
  • LSTA 08-11-2025
  • MXE 01-01-0001
  • Dividend Yield
  • LSTA N/A
  • MXE 2.66%
  • EPS Growth
  • LSTA N/A
  • MXE N/A
  • EPS
  • LSTA N/A
  • MXE N/A
  • Revenue
  • LSTA $1,000,000.00
  • MXE N/A
  • Revenue This Year
  • LSTA N/A
  • MXE N/A
  • Revenue Next Year
  • LSTA N/A
  • MXE N/A
  • P/E Ratio
  • LSTA N/A
  • MXE N/A
  • Revenue Growth
  • LSTA N/A
  • MXE N/A
  • 52 Week Low
  • LSTA $1.87
  • MXE $8.40
  • 52 Week High
  • LSTA $4.20
  • MXE $11.51
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 51.78
  • MXE 56.64
  • Support Level
  • LSTA $2.55
  • MXE $10.54
  • Resistance Level
  • LSTA $3.09
  • MXE $10.89
  • Average True Range (ATR)
  • LSTA 0.28
  • MXE 0.15
  • MACD
  • LSTA -0.01
  • MXE -0.03
  • Stochastic Oscillator
  • LSTA 48.00
  • MXE 51.32

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About MXE Mexico Equity and Income Fund Inc. (The)

Mexico Equity and Income Fund Inc is a closed-end, non-diversified management investment company. It maintains an investment objective of long-term capital appreciation through investments in securities, primarily equity, listed on the Mexican Stock Exchange. The company provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.

Share on Social Networks: